Search

everythinglearnresearchcommunity

for

Search:↓

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Dendrobium officinale polysaccharide helps hair regrowth in hair loss mice by affecting local steroid metabolism and hair follicle responses.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

OXTR agonists may promote hair growth and be effective for treating hair loss.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

DFMO may help control hair growth and treat cancer.

Dutasteride is approved to help manage prostate enlargement.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Neurosteroids may help metyrapone reduce cocaine addiction.